TNF and lymphoma: In those studies that specifically evaluated the effects of tumor necrosis factor (TNF) antagonists on lymphoma risk, there was a higher risk in RA patients receiving anti-TNF therapy compared with the general population, with SIRs of 2.9 [4] and 11.5 [10].